Evidence map›Paper›PMID 42164458›Full record

ArticleEuropean heart journal. Digital health2026

Automated echocardiographic detection of mitral valve prolapse and mitral regurgitation with video-based artificial intelligence algorithms.

Minhaj U Ansari, Joshua P Barrios, Lionel Tastet, Rohit Jhawar, Luca Cristin, Amy Rich, Dwight Bibby, Qizhi Fang, Farzin Arya, Valentina Crudo and 4 more

Abstract read
In one paragraph

Article in European heart journal. Digital health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Minhaj U AnsariDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.
Joshua P BarriosDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.
Lionel TastetDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.ORCID https://orcid.org/0000-0002-6374-5398
Rohit JhawarDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.ORCID https://orcid.org/0009-0000-6021-6418
Luca CristinDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.ORCID https://orcid.org/0009-0003-2932-8659
Amy RichDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.
Dwight BibbyDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.
Qizhi FangDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.
Farzin AryaDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.
Valentina CrudoHouston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.
Thuy NguyenHouston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.
Dipan J ShahHouston Methodist DeBakey Heart & Vascular Center, Houston, TX, USA.ORCID https://orcid.org/0000-0002-6179-2393
Francesca N DellingDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.ORCID https://orcid.org/0000-0002-5224-4096
Geoffrey H TisonDivision of Cardiology, Department of Medicine, University of California, San Francisco, Smith Cardiovascular Research Building Box 3120, 555 Mission Bay Blvd South, San Francisco, CA 94158, USA.ORCID https://orcid.org/0000-0002-0310-3326

Funding

Prospective sudden cardiac death risk stratification using CMR and echocardiography machine learning in mitral valve prolapseR01HL153447 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DELLING, FRANCESCA N · 2020 to 2024
$4.7M
NHLBI NIH HHS R01 HL153447
6 · The paper itself

Abstract

Aims: We aimed to develop and evaluate fully automated artificial intelligence (AI) system for detection of mitral valve prolapse (MVP) and mitral regurgitation (MR) from echocardiographic studies. Methods and results: We used a dataset of 24 869 echocardiographic studies from the University of California San Francisco (UCSF) to train a multi-view deep neural network (DNN) to detect MVP using apical four-chamber, two-chamber, and parasternal long-axis views. A separate dataset of 27 906 studies from UCSF was used to train a second multi-view DNN model to detect moderate-to-severe or severe MR using colour Doppler in the same views. External validation was performed on echocardiographic MVP videos from Houston Methodist Hospital. The DNN model for MVP detection achieved an area under the receiver operating characteristic curve (AUC) of 0.917 [95% confidence interval (CI): 0.899-0.934], with stronger performance in those with mitral annular disjunction (MAD) or bileaflet MVP. External validation for MVP detection in a geographically and demographically distinct population yielded an AUC of 0.835 (95% CI: 0.803-0.869). The DNN for detection of moderate-to-severe or severe MR in patients with concurrent MVP achieved an AUC of 0.877 (95% CI: 0.805-0.939). Conclusion: Artificial intelligence algorithms can perform automatic detection of MVP and clinically significant MR from echocardiogram studies with high performance. The MVP DNN performed particularly well for more severe MVP phenotypes such as MAD or bileaflet MVP. These algorithms could provide a novel approach for automated, accurate, and rapid diagnosis of MVP and its common clinical sequelae across institutions.

Indexed as

Artificial intelligenceDeep learningEchocardiographyMitral regurgitationMitral valve prolapseValvular heart disease

Identifiers

PMID42164458
PMCPMC13184616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.